Recombinant vaccines for hepatitis E. (Q34399421)

1 August 2017

1 reference

title

Recombinant vaccines for hepatitis E. (English)

1 reference

1 August 2017

Emerson SU

1 reference

1 August 2017

Purcell RH

1 reference

1 August 2017

publication date

1 October 2001

1 reference

Trends in Molecular Medicine

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

462-466

1 reference

Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Prevalence of antibodies to hepatitis E in two rural Egyptian communities

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Evidence in favour of high infection rate with hepatitis E virus among young children in India

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Brief report: experimental hepatitis E infection in domestic pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

A novel virus in swine is closely related to the human hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Genetic and experimental evidence for cross-species infection by swine hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Evidence for widespread infection of wild rats with hepatitis E virus in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Prevalence of antibody to hepatitis E virus among rodents in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Sequence data suggests big liver and spleen disease virus (BLSV) is genetically related to hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV).

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Identification of a novel strain of hepatitis E virus responsible for sporadic acute hepatitis in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Identification of 2 novel isolates of hepatitis E virus in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Animal models of hepatitis A and E.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Successful passive and active immunization of cynomolgus monkeys against hepatitis E

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

In VitroInfection and Replication of Hepatitis E Virus in Primary Cynomolgus Macaque Hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Hepatitis E virus: identification of type-common epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Purification and characterization of a recombinant hepatitis E protein vaccine candidate by liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Expression and self-assembly of empty virus-like particles of hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Antiserum generated by DNA vaccine binds to hepatitis E virus (HEV) as determined by PCR and immune electron microscopy (IEM): application for HEV detection by affinity-capture RT-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Nepal calls the shots in hepatitis E virus vaccine trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902106-2

7 January 2021

10.1016/S1471-4914(01)02106-2

Identifiers

DOI

1 reference

1 August 2017

1 reference